{
    "Symbol": "BIO",
    "AssetType": "Common Stock",
    "Name": "Bio-Rad Laboratories Inc",
    "Description": "Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.",
    "CIK": "12208",
    "Exchange": "NYSE",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "LABORATORY ANALYTICAL INSTRUMENTS",
    "Address": "1000 ALFRED NOBEL DRIVE, HERCULES, CA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2024-03-31",
    "MarketCapitalization": "9347252000",
    "EBITDA": "508326000",
    "PERatio": "None",
    "PEGRatio": "1.19",
    "BookValue": "238.73",
    "DividendPerShare": "None",
    "DividendYield": "None",
    "EPS": "-10.68",
    "RevenuePerShareTTM": "89.29",
    "ProfitMargin": "-0.517",
    "OperatingMarginTTM": "0.159",
    "ReturnOnAssetsTTM": "0.0208",
    "ReturnOnEquityTTM": "-0.174",
    "RevenueTTM": "2562604000",
    "GrossProfitTTM": "1568430000",
    "DilutedEPSTTM": "-10.68",
    "QuarterlyEarningsGrowthYOY": "4.797",
    "QuarterlyRevenueGrowthYOY": "-0.063",
    "AnalystTargetPrice": "343.4",
    "AnalystRatingStrongBuy": "0",
    "AnalystRatingBuy": "2",
    "AnalystRatingHold": "4",
    "AnalystRatingSell": "0",
    "AnalystRatingStrongSell": "0",
    "TrailingPE": "-",
    "ForwardPE": "30.86",
    "PriceToSalesRatioTTM": "3.648",
    "PriceToBookRatio": "1.075",
    "EVToRevenue": "3.55",
    "EVToEBITDA": "-13.07",
    "Beta": "0.93",
    "52WeekHigh": "406.44",
    "52WeekLow": "261.59",
    "50DayMovingAverage": "292.75",
    "200DayMovingAverage": "307.63",
    "SharesOutstanding": "23445700",
    "DividendDate": "None",
    "ExDividendDate": "None"
}